Statement Of Financial Position [Abstract]

GenSight Biologics S.A. - Filing #5982864

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Intangible assets other than goodwill
57,000 EUR
75,000 EUR
Cash and cash equivalents
2 464 EUR
2,134,000 EUR
10,610,000 EUR
Assets
10 756 EUR
9,132,000 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
3 119 EUR
1,633,000 EUR
Share premium
206 606 EUR
190,937,000 EUR
Equity
206 606 EUR
26 920 EUR
3 119 EUR
222 644 EUR
14 001 EUR
190,937,000 EUR
1,633,000 EUR
30,702,000 EUR
197,051,000 EUR
26,220,000 EUR
15,279,000 EUR
181,211,000 EUR
170,024,000 EUR
1,158,000 EUR
27,625,000 EUR
Equity and liabilities
10 756 EUR
9,132,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.